If there was a Board meeting on 4 January, as you were advised, the need for an urgent shareholder update explaining the reasons for missing the revised timetable for a Japanese licensing deal on Progenza and setting out the 'where to from here' was obviously not on the agenda.
As Panorama has observed, shareholders do deserve better.
zeno9
Still no deal?!?, page-42
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
